Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome

Clinical trial NCT02979366 · COMPLETED

Trial details

NCT number: NCT02979366
Sponsor: Institut de Recherches Internationales Servier
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukaemia (AML)Myelodysplastic Syndrome (MDS)

Start date: 2017-03-15
Primary completion: 2020-05-11
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.